Details for New Drug Application (NDA): 206928
✉ Email this page to a colleague
The generic ingredient in GLIPIZIDE is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.
Summary for 206928
Tradename: | GLIPIZIDE |
Applicant: | Aurobindo Pharma |
Ingredient: | glipizide |
Patents: | 0 |
Suppliers and Packaging for NDA: 206928
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GLIPIZIDE | glipizide | TABLET, EXTENDED RELEASE;ORAL | 206928 | ANDA | A-S Medication Solutions | 50090-4297 | 50090-4297-0 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4297-0) |
GLIPIZIDE | glipizide | TABLET, EXTENDED RELEASE;ORAL | 206928 | ANDA | A-S Medication Solutions | 50090-4297 | 50090-4297-2 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4297-2) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 2.5MG | ||||
Approval Date: | May 12, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 5MG | ||||
Approval Date: | May 12, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
Approval Date: | May 12, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription